Notice: This company has been marked as potentially delisted and may not be actively trading. Acceleron Pharma (XLRN) News Today Add Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Acceleron Fusion has raised $15M to take a stab at colder fusion, filing revealsOctober 5, 2024 | techcrunch.comAcceleron Fusion has raised $15M to take another stab at cold fusion, filing revealsOctober 1, 2024 | yahoo.comORBIMED CAPITAL GP II LLC's Net WorthFebruary 27, 2024 | benzinga.comXLRN Historical DataOctober 20, 2023 | investing.comBrexit Bargain Buys: 14 More Stocks Picked by Morgan StanleyApril 15, 2023 | thestreet.comAstellas Pharma IncMarch 17, 2023 | reuters.comAcceleron Corp Becomes a Digital Correspondent BankDecember 14, 2022 | finance.yahoo.comPharma Contract Sales Market Report 2022-2032November 30, 2022 | finance.yahoo.comMerck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugsNovember 21, 2022 | reuters.comCentre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular TrialOctober 10, 2022 | msn.comLiquidia slumps as United, MannKind get FDA nod for rival therapyMay 23, 2022 | seekingalpha.com19 Charts to Calm Your Recession FearsJanuary 20, 2022 | thestreet.comXLRN May 2022 140.000 putDecember 22, 2021 | finance.yahoo.comMerck Closes Biggest Biotech Deal of the YearNovember 22, 2021 | finance.yahoo.comMerck announces completion of Acceleron Pharma acquisitionNovember 22, 2021 | seekingalpha.comTrading was temporarily halted for "XLRN" at 07:11 PM with a stated reason of "News pending."November 22, 2021 | marketbeat.comMerck's (NYSE:MRK) Balance Sheet Can Easily Handle Acquisitions like Acceleron Pharma (NASDAQ: XLRN)November 21, 2021 | nasdaq.comAvoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate OfferNovember 17, 2021 | apnews.comNotable Wednesday Option Activity: XLRN, LOW, ZGNXNovember 17, 2021 | nasdaq.comMerck Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Extension of Tender Offer to Acquire Acceleron Pharma Inc.November 17, 2021 | finance.yahoo.comMerck says HSR waiting period for Acceleron Pharma deal expiresNovember 17, 2021 | seekingalpha.comAvoro Capital Advisors LLC Buys Acceleron Pharma Inc, Apellis Pharmaceuticals Inc, Aadi ...November 15, 2021 | gurufocus.comWestern Standard LLC Buys IHS Markit, Acceleron Pharma Inc, Marlin Business Services Corp, ...November 15, 2021 | gurufocus.comSome Acceleron Investors Want a Better Deal From MerckNovember 12, 2021 | finance.yahoo.comIs Merck's Planned Acquisition of Acceleron in Trouble?November 12, 2021 | msn.comAvoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate OfferNovember 9, 2021 | finance.yahoo.comAcceleron: Q3 Earnings SnapshotNovember 4, 2021 | chron.comAcceleron Reports Third Quarter 2021 Financial ResultsNovember 4, 2021 | finance.yahoo.comWhy Earnings Season Could Be Great for Acceleron Pharma (XLRN)November 3, 2021 | finance.yahoo.comNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Acceleron Pharma Inc. (Nasdaq - XLRN), Kraton Corporation (NYSE - KRA), Dawson Geophysical Company (Nasdaq – DWSN)November 2, 2021 | finance.yahoo.comFarallon Capital Opposes Terms of Merck’s Acceleron TakeoverNovember 2, 2021 | finance.yahoo.comMerck Pushes Acceleron Buyout By Refiling For Antitrust ReviewNovember 1, 2021 | finance.yahoo.comMerck to Refile Notification of Acceleron Merger Deal, Extending Deadline for ShareholdersOctober 30, 2021 | finance.yahoo.comAvoro Capital Slams Merck's $11.5B Acceleron DealOctober 28, 2021 | law360.comEarnings Preview: Acceleron Pharma (XLRN) Q3 Earnings Expected to DeclineOctober 28, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Continues an Investigation of Acceleron Pharma Inc. (Nasdaq - XLRN)October 28, 2021 | finance.yahoo.comAvoro Capital Issues Open Letter to Fellow Acceleron Pharma ShareholdersOctober 28, 2021 | finance.yahoo.comAcceleron Announces Third Quarter 2021 REBLOZYL® Net SalesOctober 27, 2021 | finance.yahoo.comMerck (MRK) to Report Q3 Earnings: What's in the Cards?October 25, 2021 | finance.yahoo.comBristol-Myers Plans to Exit Acceleron Stake With Merck DealOctober 21, 2021 | finance.yahoo.comACCELERON PHARMA ALERT: Investors Should Contact Bragar Eagel & Squire, P.C. Over Tender Offer for XLRN SharesOctober 18, 2021 | finance.yahoo.com(XLRN): Johnson Fistel Investigates Proposed Sale of Acceleron Pharma; Is $180 a Fair Price?October 15, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acceleron Pharma Inc. - XLRNOctober 13, 2021 | finance.yahoo.comHolocene Advisors says Merck’s offer undervalues AcceleronOctober 13, 2021 | financialpost.comMerck Begins Tender Offer to Acquire Acceleron Pharma Inc.October 12, 2021 | finance.yahoo.com3 Reasons to Buy Merck Stock Right NowOctober 9, 2021 | finance.yahoo.comIs an Acquisition of Acceleron a Smart Move for Merck?October 8, 2021 | msn.comNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Acceleron Pharma Inc. (NASDAQ:XLRN), Sanderson Farms, Inc. (NASDAQ:SAFM), JMP Group LLC (NYSE:JMP)October 7, 2021 | finance.yahoo.comMERGER ALERT - TGP, XLRN, and VNE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these CompaniesOctober 6, 2021 | finance.yahoo.comWhere Acceleron Pharma Stands With AnalystsOctober 4, 2021 | markets.businessinsider.com Get Acceleron Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide XLRN Media Mentions By Week XLRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XLRN News Sentiment▼0.000.47▲Average Medical News Sentiment XLRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XLRN Articles This Week▼00▲XLRN Articles Average Week Get Acceleron Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XLRN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acceleron Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acceleron Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XLRN Stock Alerts